Alnylam Pharmaceuticals
ALNY
#631
Rank
โ‚น3.829 T
Marketcap
โ‚น28,685
Share price
-1.01%
Change (1 day)
10.13%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company